Junliang Tong

Statistics

Publications

Citations

258

H-Index

Active since

2014

Affiliations

Optum (United States)(Current)

Junliang Tong is an author at Optum (United States) specializing in long-acting muscarinic antagonist combinations, infectious diseases, and pharmacotherapy.

Publications per year

2014–2020

Publications

Using electronic health records to estimate the prevalence of agitation in Alzheimer disease/dementia

Rachel Halpern, Jerald Seare, Junliang Tong et al. · International Journal of Geriatric Psychiatry · 2018 · 107 citations · Full text

Medicine, Geriatric Medicine, Psychiatry +17

Predicting and analyzing the COVID-19 epidemic in China: Based on SEIRD, LSTM and GWR models

Fenglin Liu, Jie Wang, Jiawen Liu et al. · PLoS ONE · 2020 · 67 citations · Full text

Veterinary Medicine, Infectious Disease Control, Infectious Diseases +17

The Relationships of Physician Practice Characteristics to Quality of Care and Costs

John E. Kralewski, Bryan Dowd, David Knutson et al. · Health Services Research · 2014 · 32 citations · Full text

Health Professions, Health Administration, Health Services Administration +17

<p>Real-world effectiveness of umeclidinium/vilanterol versus fluticasone propionate/salmeterol as initial maintenance therapy for chronic obstructive pulmonary disease (COPD): a retrospective cohort study</p>

Chad Moretz, Lucie Sharpsten, Lindsay G.S. Bengtson et al. · International Journal of COPD · 2019 · 21 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +17

<p>Evaluation of rescue medication use and medication adherence receiving umeclidinium/vilanterol versus tiotropium bromide/olodaterol</p>

Chad Moretz, Lindsay G.S. Bengtson, Lucie Sharpsten et al. · International Journal of COPD · 2019 · 17 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +13

1–5 of 6